Search Results - "Hölscher, Arnulf H"

Prognostic Classification of Histopathologic Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma by Hölscher, Arnulf H., Drebber, Uta, Schmidt, Henner, Bollschweiler, Efriede

“…To evaluate the histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma according to impact on prognosis and to suggest a classification…”
Get full text

Incidence and grading of complications after gastrectomy for cancer using the GASTRODATA registry : a European retrospective observational study by Baiocchi, Gian Luca, Giacopuzzi, Simone, Reim, Daniel, Piessen, Guillaume, Costa, Paulo Matos, Reynolds, John V, Meyer, Hans-Joachim, Morgagni, Paolo, Gockel, Ines, Santos, Lucio Lara, Jensen, Lone Susanne, Murphy, Thomas, D'Ugo, Domenico, Rosati, Riccardo, Fumagalli Romario, Uberto, Degiuli, Maurizio, Kielan, Wojciech, Mönig, Stefan, Kołodziejczyk, Piotr, Polkowski, Wojciech, Pera, Manuel, Schneider, Paul M, Wijnhoven, Bas, de Steur, Wobbe O, Gisbertz, Suzanne S, Hartgrink, Henk, van Sandick, Johanna W, Botticini, Maristella, Hölscher, Arnulf H, Allum, William, De Manzoni, Giovanni

“…Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. Objective: Utilizing a standardized dataset based on a newly developed list of 27 univocally…”
Get full text

Diagnostic marker signature for esophageal cancer from transcriptome analysis by Warnecke-Eberz, Ute, Metzger, Ralf, Hölscher, Arnulf H., Drebber, Uta, Bollschweiler, Elfriede

“…Esophageal cancer is often diagnosed at an advanced stage. Diagnostic markers are needed for achieving a cure in esophageal cancer detecting and treating tumor…”
Get full text

A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer by Vallböhmer, D, Hölscher, Arnulf H, DeMeester, S, DeMeester, T, Salo, J, Peters, J, Lerut, T, Swisher, S G, Schröder, W, Bollschweiler, E, Hofstetter, W

“…To evaluate 5-year survival of patients with locally advanced esophageal cancer (LAEC) who have undergone multimodality treatment with complete histopathologic…”
Get full text

Impact of Extracapsular Lymph Node Involvement After Neoadjuvant Chemoradiation Therapy Followed by Surgery in Carcinoma of the Esophagus: A Multicenter Study by Depypere, Lieven P, Moons, Johnny, Mariette, Christophe, D’Journo, Xavier B, Thomas, Pascal A, Hölscher, Arnulf H, Bollschweiler, Elfriede, van Berge-Henegouwen, Mark I, Van Lanschot, Jan J B, Lerut, Toni E. M R, Nafteux, Philippe R

“…OBJECTIVES:The current study aims to examine the impact of extracapsular lymph node involvement (EC-LNI) on survival for both esophageal adenocarcinoma (AC)…”
Get full text

[18F]-Fluorodeoxyglucose-Positron Emission Tomography for the Assessment of Histopathologic Response and Prognosis After Completion of Neoadjuvant Chemoradiation in Esophageal Cancer by VALLBÖHMER, Daniel, HÖLSCHER, Arnulf H, DIETLEIN, Markus, BOLLSCHWEILER, Elfriede, BALDUS, Stephan E, MÖNIG, Stefan P, METZGER, Ralf, SCHICHA, Harald, SCHMIDT, Matthias

“…To evaluate the potential of [(18)F]-fluorodeoxyglucose-positron emission tomography (FDG-PET) after the completion of neoadjuvant chemoradiation for the…”
Get full text

Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach by Bollschweiler, Elfriede, Hölscher, Arnulf H., Markar, Sheraz R., Alakus, Hakan, Drebber, Uta, Mönig, Stefan Paul, Plum, Patrick Sven

“…Objective To establish the life expectancy burden of esophago‐gastric cancer by analyzing years of life lost (YLL) for a Western patient population after…”
Get full text

B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies by Schlößer, Hans A., Thelen, Martin, Lechner, Axel, Wennhold, Kerstin, Garcia-Marquez, Maria A., Rothschild, Sacha I., Staib, Elena, Zander, Thomas, Beutner, Dirk, Gathof, Birgit, Gilles, Ramona, Cukuroglu, Engin, Göke, Jonathan, Shimabukuro-Vornhagen, Alexander, Drebber, Uta, Quaas, Alexander, Bruns, Christiane J., Hölscher, Arnulf H., Von Bergwelt-Baildon, Michael S.

“…Tumor-infiltrating lymphocytes (TILs) are correlated to prognosis of several kinds of cancer. Most studies focused on T cells, while the role of…”
Get full text

Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus by Plum, Patrick Sven, Ulase, Dita, Bollschweiler, Elfriede, Chon, Seung-Hun, Berlth, Felix, Zander, Thomas, Alakus, Hakan, Hölscher, Arnulf H., Bruns, Christiane J., Schallenberg, Simon, Quaas, Alexander, Loeser, Heike

“…Purpose Therapeutic decisions in esophageal adenocarcinomas (EAC) restricted to mucosa (pT1a) or submucosa (pT1b) depend mainly on classic…”
Get full text

Prognostic Relevance of Lymph Node Regression After Neoadjuvant Chemoradiation for Esophageal Cancer by Philippron, Annouck, MD, Bollschweiler, Elfriede, MD, PhD, Kunikata, Ayumi, MD, Plum, Patrick, MD, Schmidt, Claudia, MD, Favi, Francesco, MD, Drebber, Uta, MD, Hölscher, Arnulf H., MD

“…Prognostic factors after preoperative chemoradiation for patients with advanced esophageal cancer are under discussion. Treatment response measured in the…”
Get full text

MUC1 and Nuclear β-Catenin Are Coexpressed at the Invasion Front of Colorectal Carcinomas and Are Both Correlated with Tumor Prognosis by BALDUS, Stephan E, MÖNIG, Stefan P, HUXEL, Sandra, LANDSBERG, Stephanie, HANISCH, Franz-Georg, ENGELMANN, Katja, SCHNEIDER, Paul M, THIELE, Jürgen, HÖLSCHER, Arnulf H, DIENES, Hans P

“…Purpose: Overexpression of MUC1 and cytosolic interaction of the mucin with β-catenin are claimed to be involved in colorectal carcinogenesis. In vitro data…”
Get full text

Reply to Letter: “For Patients With Early Esophageal Cancer Endoscopic Mucosa Resection Is Not the End of the Story!” by Pech, Oliver, Manner, Hendrik, Ell, Christian, Bollschweiler, Elfriede, Hölscher, Arnulf H

Get full text

Prognostic Relevance of Skip Metastases in Esophageal Cancer by Prenzel, Klaus L., MD, Bollschweiler, Elfriede, MD, Schröder, Wolfgang, MD, Mönig, Stefan P., MD, Drebber, Uta, MD, Vallboehmer, Daniel, MD, Hölscher, Arnulf H., MD

“…Background Presence of nodal skip metastasis is an established prognostic factor for patients with non–small cell lung cancer. Little is known about this form…”
Get full text

Prognostic Significance of a New Grading System of Lymph Node Morphology After Neoadjuvant Radiochemotherapy for Esophageal Cancer by Bollschweiler, Elfriede, MD, PhD, Hölscher, Arnulf H., MD, Metzger, Ralf, MD, Besch, Sarah, MD, Mönig, Stefan P., MD, Baldus, Stephan E., MD, Drebber, Uta, MD

“…Background Along with primary tumor response, lymph node (LN) status after radiochemotherapy is one of the most important prognostic factors for advanced…”
Get full text

Epidermal Growth Factor Receptor and HER2-neu mRNA Expression in Non-Small Cell Lung Cancer Is Correlated with Survival by Brabender, J, Danenberg, K D, Metzger, R, Schneider, P M, Park, J, Salonga, D, Hölscher, A H, Danenberg, P V

“…The prognostic role of epidermal growth factor receptor (EGFR) and HER2-neu remains controversial in patients with non-small cell lung cancer (NSCLC). We…”
Get full text

Patient, Surgeon, and Health Care Worker Safety during the COVID-19 Pandemic by Hölscher, Arnulf H.

Get full text

Design, Realization, and First Validation of an Immersive Web-Based Virtual Patient Simulator for Training Clinical Decisions in Surgery by Kleinert, Robert, MD, Heiermann, Nadine, MD, Wahba, Roger, MD, Chang, De-Huan, MD, Hölscher, Arnulf H., MD, PhD, Stippel, Dirk L., MD, PhD

“…Background Immersive patient simulators (IPS) allow an illusionary immersion into a synthetic world where the user can freely navigate through a 3-dimensional…”
Get full text

Influence of Neoadjuvant Chemoradiation on the Number and Size of Analyzed Lymph Nodes in Esophageal Cancer by Bollschweiler, Elfriede, Besch, Sarah, Drebber, Uta, Schröder, Wolfgang, Mönig, Stefan P., Vallböhmer, Daniel, Baldus, Stephan E., Metzger, Ralf, Hölscher, Arnulf H.

“…Background Studies have shown that along with primary tumor response, lymph node status after RTx/CTx is one of the most important prognostic factors for…”
Get full text

Ischemic Conditioning of the Gastric Conduit Prior to Esophagectomy Improves Mucosal Oxygen Saturation by Bludau, Marc, MD, Hölscher, Arnulf H., MD, FACS, Vallböhmer, Daniel, MD, Gutschow, Christian, MD, Schröder, Wolfgang, MD

“…Background Ischemic conditioning of the gastric conduit is considered as a possible approach to improve perfusion of the gastric tube after esophagectomy. The…”
Get full text

New approaches in esophageal carcinomas by Hölscher, Arnulf H., Babic, Benjamin

“…New approaches in the treatment of esophageal cancer comprise endoscopy with refinements of esophagoscopic intraluminal resection by endoscopic submucosal…”
Get full text